3Paoliechi A,Emdin M,Passino C,et al. Beta-lipoprotein and LDLassociated serum gamma-glu -tamy ltransferase in patients with cor-onaryather osclerosis. Atherosclerosis ,2006,186 (1 ) : 80-85.
4Weich V, Herrmann E, Chung TL, et al. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection[J]. J Gastroenterol,2011,46( 12): 1427-1436.
5Coban S, Idilman R, Erden E, et al. Gamma-glutamyl transpeptidase in predicting sustained virological response in individuals with chronic hepatitis C[J]. Hepatogastroenterology,2011,58( 109): 1301 - 1306.
6Everhart JE, Wright EC. Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV)[J]. Hepatology,2013,57(5):1725-1733.
7European Association for the Study of the Liver. EASL clinical practice guidelines:management of cholestatic liver diseases[J]. J Hepatol,2009,51 (2):237-267.
8Michael Brown J, Ball JG, Wright MS. Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function[J]. Toxicol Lett,2012,212(3):320-328.
9Vardar R, Vardar E, Demiri S, et al. Is there any non- invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis[J]. Hepatogastroenterology,2009,56(94-95 ): 1459-1465.
10Fung J, Lai CL, Fong DY, et al. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis[J]. Liver Int,2008,28(10): 1408- 1416.
